Sutro Biopharma: Funding, Investors & Team (Sep 2026)
Sutro Biopharma is a company in the clinical stage of drug discovery, development, and manufacturing. They focus on creating biopharmaceutical products, specifically next-generation protein therapeutics for cancer and autoimmune diseases. Their proprietary technology, XpressCF, is used to manufacture these products. They offer STRO-001 for multiple myeloma and non-Hodgkin lymphoma patients and STRO-002 for ovarian and endometrial cancer treatment.
Sutro Biopharma has raised $215M across 2 funding rounds on record, the most recent an undisclosed round of $75.0M announced in Apr 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Sutro Biopharma Company Profile and Key Stats
Latest funding round on record: Apr 2024.
Sutro Biopharma Funding Rounds
Sutro Biopharma raised $140M in an undisclosed round announced in Jun 2023.
10 months later, an undisclosed round of $75.0M was announced in Apr 2024.
Sutro Biopharma Founders and Leadership Team
No contact details are on record for this team yet.
Sutro Biopharma Funding Compared to Other Biotechnology Startups
Sutro Biopharma's latest round of $75.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Sutro Biopharma in Biotechnology and South San Francisco
Companies Similar to Sutro Biopharma
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Sutro Biopharma Funding FAQs
What does Sutro Biopharma do?
Sutro Biopharma is a company in the clinical stage of drug discovery, development, and manufacturing. They focus on creating biopharmaceutical products, specifically next-generation protein therapeutics for cancer and autoimmune diseases. Their proprietary technology, XpressCF, is used to manufacture these products. They offer STRO-001 for multiple myeloma and non-Hodgkin lymphoma patients and STRO-002 for ovarian and endometrial cancer treatment.
How much funding has Sutro Biopharma raised?
Sutro Biopharma has raised $215M across 2 rounds on record. The most recent is an undisclosed round of $75.0M announced in Apr 2024.
When did Sutro Biopharma last raise funding?
Sutro Biopharma's most recent funding round on record is an undisclosed round of $75.0M, announced in Apr 2024.
Who founded Sutro Biopharma?
FundedIQ lists James R Swartz (Founder) at Sutro Biopharma.
Where is Sutro Biopharma headquartered?
Sutro Biopharma is based in South San Francisco, California, United States.
How many employees does Sutro Biopharma have?
Sutro Biopharma is in the 251-500 employee band.
How does Sutro Biopharma's funding compare to other Biotechnology startups?
Sutro Biopharma's latest round of $75.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Sutro Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Sutro Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.